BMI's role in ovarian cancer risk is weak, but higher BMI may influence premenopausal women, hormone therapy users, and insulin resistance, affecting cancer development and survival rates.

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination ...

The seventh warning indicator of poor ovary health or ovarian cancer is a visible change in the bowel movement. Studies have ...

Accelerated approval was based on the Phase 2 RAMP 201 study that demonstrated a 44% overall response rate in patients with KRAS-mutated recurrent low-grade serous ovarian cancer, the company said.

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Hot Rod Harriet was introduced to Constantine, a.k.a Chuck, in 1956. They fell hopelessly and madly in love and were married ...

A woman's chances of surviving ovarian cancer at least five years after diagnosis come down to the toss of a coin: just 49% ...

AUSTIN, TX / ACCESS Newswire / May 7, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering the leading tools ...

The Needham, Mass., company's shares ... response rate in patients with KRAS-mutated recurrent low-grade serous ovarian cancer, the company said. Verastem said it is conducting a confirmatory ...

A woman who went through menopause at aged 15 says it left her with the “skeleton of a 75-year-old” and she would break bones ...